"10.1371_journal.pone.0071264","plos one","2013-08-12T00:00:00Z","Amir Goren; Xianchen Liu; Shaloo Gupta; Teresa A Simon; Hemant Phatak","Health Outcomes Practice, Kantar Health, New York, New York, United States of America; Indiana University Department of Psychiatry, Indianapolis, Indiana, United States of America; Pfizer Primary Care BU, Pfizer, Inc., New York, New York, United States of America; Health Outcomes Practice, Kantar Health, Princeton, New Jersey, United States of America; Global Pharmacovigilence and Epidemiology, Bristol-Myers Squibb, Pennington, New Jersey, United States of America; Global Health Economics & Outcomes Research, Bristol-Myers Squibb, Princeton, New Jersey, United States of America","Conceived and designed the experiments: AG XL SG TAS HP. Performed the experiments: AG SG. Analyzed the data: AG SG. Wrote the paper: AG XL SG TAS HP.","Xianchen Liu is an employee of Pfizer, Inc. Teresa Simon and Hemant Phatak are employees of Bristol-Myers Squibb, which sponsored this study. Amir Goren and Shaloo Gupta are employees of Kantar Health who were paid consultants to BMS and Pfizer in connection with conducting this study and the development of this manuscript. Martine C. Maculaitis, MA, who is acknowledged for contributing to background research and editorial assistance, is a paid consultant of Kantar Health. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","08","Amir Goren","AG",5,TRUE,5,2,2,5,TRUE,TRUE,FALSE,0,NA,FALSE
